Keyphrases
Rheumatoid Arthritis Treatment
100%
Sarilumab
100%
IL-6 Blockade
100%
Rheumatoid Arthritis
71%
Interleukin-6
57%
Clinical Trials
14%
Inflammation
14%
Rheumatoid Arthritis Patients
14%
High Affinity
14%
Potential Therapeutics
14%
Expert Opinion
14%
Beta-blockers
14%
Pharmacologic
14%
Highly Active
14%
U.S. Food
14%
Active Disease
14%
Area Cover
14%
Adverse Events Profile
14%
Pharmacological Properties
14%
Therapeutic Proteins
14%
Joint Damage
14%
Clinical Trial Results
14%
Tocilizumab
14%
Target Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Sarilumab
100%
Receptor
11%
Clinical Trial
11%
Disease
11%
Adverse Event
11%
Interleukin 6
11%
Inflammation
11%
Cytokine
11%
Biological Product
11%
Clinical Trial Results
11%
Tocilizumab
11%